Literature DB >> 11026610

Inhalation studies in laboratory animals--current concepts and alternatives.

J Pauluhn1, U Mohr.   

Abstract

Highly standardized and controlled inhalation studies are required for hazard identification to make test results reproducible and comparable and to fulfill general regulatory requirements for the registration of new drugs, pesticides, or chemicals. Despite significant efforts, the results of inhalation studies have to be analyzed judiciously due to the great number of variables. These variables may be related to technical issues or to the specific features of the animal model. Although inhalation exposure of animals mimics human exposure best, ie, error-prone route-to-route extrapolations are not necessary, not all results obtained under such very rigorous test conditions may necessarily also occur under real-life exposure conditions. Attempts are often made to duplicate as closely as possible these real-life exposure conditions of humans in appropriate bioassays. However, this in turn might affect established baseline data, rendering the interpretation of new findings difficult. In addition, specific use patterns, eg, of inhalation pharmaceuticals or pesticide-containing consumer products, may impose test agent-specific constraints that challenge traditional approaches. Moreover, specific modes of action of the substance under investigation, the evaluation of specific endpoints, or the clarification of equivocal findings in common rodent species may require exposure paradigms or the use of animal species not commonly used in inhalation toxicology. However, particularly in inhalation toxicology, the choice of animal models for inhalation toxicity testing is usually based on guideline requirements and practical considerations, such as exposure technology, expediency, and previous experience rather than validity for use in human beings. Larger animal species, apart from the welfare aspects, may require larger inhalation chambers to accommodate the animals, but for technical reasons and the difficulty of generating homogeneous exposure atmospheres in such inhalation chambers, this may jeopardize the outcome of the study. Some of the many variables and possible artifacts likely to occur in animal inhalation studies are addressed in this paper.

Entities:  

Mesh:

Year:  2000        PMID: 11026610     DOI: 10.1177/019262330002800514

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  7 in total

1.  Inhalation of particulate matter containing free radicals leads to decreased vascular responsiveness associated with an altered pulmonary function.

Authors:  Ashlyn C Harmon; Alexandra Noël; Balamurugan Subramanian; Zakia Perveen; Merilyn H Jennings; Yi-Fan Chen; Arthur L Penn; Kelsey Legendre; Daniel B Paulsen; Kurt J Varner; Tammy R Dugas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-08-20       Impact factor: 5.125

2.  Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of Asthma.

Authors:  Jonathan E Phillips; Lorena Renteria; Lisa Burns; Paul Harris; Ruoqi Peng; Carla M T Bauer; Dramane Laine; Christopher S Stevenson
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-04-25       Impact factor: 2.849

3.  Determination of methyl isopropyl hydantoin from rat erythrocytes by gas-chromatography mass-spectrometry to determine methyl isocyanate dose following inhalation exposure.

Authors:  Brian A Logue; Zhiling Zhang; Erica Manandhar; Adam L Pay; Claire R Croutch; Eric Peters; William Sosna; Jacqueline S Rioux; Livia A Veress; Carl W White
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-07-05       Impact factor: 3.205

Review 4.  Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.

Authors:  Tony Velkov; Nusaibah Abdul Rahim; Qi Tony Zhou; Hak-Kim Chan; Jian Li
Journal:  Adv Drug Deliv Rev       Date:  2014-11-12       Impact factor: 15.470

5.  Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System.

Authors:  Jonathan E Phillips; Xuxia Zhang; James A Johnston
Journal:  J Vis Exp       Date:  2017-04-06       Impact factor: 1.355

6.  Octachlorodipropyl ether (s-2) mosquito coils are inadequately studied for residential use in Asia and illegal in the United States.

Authors:  Robert I Krieger; Travis M Dinoff; Xiaofei Zhang
Journal:  Environ Health Perspect       Date:  2003-09       Impact factor: 9.031

7.  Impact of whole-body versus nose-only inhalation exposure systems on systemic, respiratory, and cardiovascular endpoints in a 2-month cigarette smoke exposure study in the ApoE-/- mouse model.

Authors:  Ulrike Kogel; Ee Tsin Wong; Justyna Szostak; Wei Teck Tan; Francesco Lucci; Patrice Leroy; Bjoern Titz; Yang Xiang; Tiffany Low; Sin Kei Wong; Emmanuel Guedj; Nikolai V Ivanov; Walter K Schlage; Manuel C Peitsch; Arkadiusz Kuczaj; Patrick Vanscheeuwijck; Julia Hoeng
Journal:  J Appl Toxicol       Date:  2021-04-06       Impact factor: 3.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.